Andy Johnson, Executive Director of Medical Affairs, at Summit Therapeutics, shared on LinkedIn:
“I’m excited to share that I’ve joined Summit Therapeutics as Executive Director, Medical Affairs for lung cancer to help develop ivonescimab.
Thank you so much to everyone who helped me, provided guidance, and trusted in me during an incredible 5+ years with J/J. I will take with me the extensive learnings and enduring friendships from the many wonderful colleagues I had the pleasure to work with.
It’s a privilege to do my part in our collective battle against cancer and support for those impacted by it. The patients are waiting.”